A new classification for hepatocellular carcinoma enhances predictive accuracy for overall survival. In a study involving 1,766 patients, incorporating the tumor burden score (TBS) allowed reclassification into distinct categories, revealing improved five-year survival rates: the TBS-br model yielded rates of 70.8%, 58.3%, and 40.0% compared to the original boundary category’s 65.1%, 48.2%, and 46.4%. This […]

In a first-in-human trial, SmartPAN hydrogel proved safe and easy to use for visualizing intraoperative pancreatic leakage during partial resections. Out of 29 patients receiving SmartPAN, 10 demonstrated positive leakage responses, with postoperative pancreatic fistula (POPF) occurring in 7 patients. Surgeons rated the device highly for its usability and expressed intent to use it frequently. […]

A machine learning model successfully predicted textbook outcomes in liver surgery using preoperative data from over 2,000 patients. The top-performing xgboost model achieved an area under the curve of 0.73. Significant predictors included minimally invasive techniques and patient characteristics such as lower comorbidity scores. Furthermore, meeting textbook outcome criteria was associated with improved overall survival, […]

A study on pancreatic ductal adenocarcinoma reveals that conditional survival analysis based on kallikrein-related peptidase 7 (klk7) expression can significantly improve prognostic assessments. Results show that 1-, 2-, and 3-year conditional survival rates increased from 50.4% to 91.2%, while overall survival rates dropped from 81.9% to 38.6%. Patients surviving longer periods demonstrate improved future survival […]

Dynamic changes in serum AST and ALT levels after liver resection for hepatocellular carcinoma were shown to significantly impact postoperative morbidity. In a study involving 759 patients, an increase in the combined assessment of AST and ALT (caa) to ≥5 was strongly linked to higher complication rates, with an odds ratio of 1.63. The study […]

A systematic review and meta-analysis evaluated textbook outcomes (TOs) in hepatopancreaticobiliary (HPB) surgery across 27 studies involving 517,304 patients. It revealed a median TO achievement rate of 62% for hepatic procedures, 54% for biliary, and lower rates for pancreatic and liver transplantation surgeries. Importantly, achieving TOs was linked to an increased likelihood of 5-year overall […]

A study involving 165 patients diagnosed with hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) identified alpha-fetoprotein (AFP) and carbohydrate antigen 19-9 (CA19-9) as key tumor markers for accurate preoperative differentiation. Elevated white blood cell counts, neutrophil-to-lymphocyte ratios, and monocyte counts were linked to increased ICC risk, while higher lymphocyte-to-monocyte ratios indicated protection. The predictive model […]

A systematic review of 156 studies on curative surgery for pancreatic adenocarcinoma reveals significant inconsistencies in outcome reporting. Researchers identified 2088 reported outcomes, resulting in 399 unique endpoints, with no single outcome universally reported. Alarmingly, 45% of these outcomes were undefined, indicating a lack of clarity. Most outcomes focused on adverse events and care delivery, […]

Soluble TREM2 (strem2) levels in plasma effectively reflect liver fibrosis status and predict postoperative liver dysfunction in patients undergoing liver resection. In a cohort of 108 patients assessed before surgery and on postoperative days one and five, strem2 demonstrated sensitivity for early, asymptomatic chronic liver disease. Notably, even patients without end-stage liver disease showed distinct […]